SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling

The epigenetic mechanisms of melanoma drug resistance are poorly understood. Here, the authors develop a CRISPR-Cas9 screen targeting epigenetic regulators and discover that SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas Strub, Flavia G. Ghiraldini, Saul Carcamo, Man Li, Aleksandra Wroblewska, Rajendra Singh, Matthew S. Goldberg, Dan Hasson, Zichen Wang, Stuart J. Gallagher, Peter Hersey, Avi Ma’ayan, Georgina V. Long, Richard A. Scolyer, Brian Brown, Bin Zheng, Emily Bernstein
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/bec741aeed1b4f7292b8e63eab1bc699
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bec741aeed1b4f7292b8e63eab1bc699
record_format dspace
spelling oai:doaj.org-article:bec741aeed1b4f7292b8e63eab1bc6992021-12-02T17:31:15ZSIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling10.1038/s41467-018-05966-z2041-1723https://doaj.org/article/bec741aeed1b4f7292b8e63eab1bc6992018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05966-zhttps://doaj.org/toc/2041-1723The epigenetic mechanisms of melanoma drug resistance are poorly understood. Here, the authors develop a CRISPR-Cas9 screen targeting epigenetic regulators and discover that SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.Thomas StrubFlavia G. GhiraldiniSaul CarcamoMan LiAleksandra WroblewskaRajendra SinghMatthew S. GoldbergDan HassonZichen WangStuart J. GallagherPeter HerseyAvi Ma’ayanGeorgina V. LongRichard A. ScolyerBrian BrownBin ZhengEmily BernsteinNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Thomas Strub
Flavia G. Ghiraldini
Saul Carcamo
Man Li
Aleksandra Wroblewska
Rajendra Singh
Matthew S. Goldberg
Dan Hasson
Zichen Wang
Stuart J. Gallagher
Peter Hersey
Avi Ma’ayan
Georgina V. Long
Richard A. Scolyer
Brian Brown
Bin Zheng
Emily Bernstein
SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
description The epigenetic mechanisms of melanoma drug resistance are poorly understood. Here, the authors develop a CRISPR-Cas9 screen targeting epigenetic regulators and discover that SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.
format article
author Thomas Strub
Flavia G. Ghiraldini
Saul Carcamo
Man Li
Aleksandra Wroblewska
Rajendra Singh
Matthew S. Goldberg
Dan Hasson
Zichen Wang
Stuart J. Gallagher
Peter Hersey
Avi Ma’ayan
Georgina V. Long
Richard A. Scolyer
Brian Brown
Bin Zheng
Emily Bernstein
author_facet Thomas Strub
Flavia G. Ghiraldini
Saul Carcamo
Man Li
Aleksandra Wroblewska
Rajendra Singh
Matthew S. Goldberg
Dan Hasson
Zichen Wang
Stuart J. Gallagher
Peter Hersey
Avi Ma’ayan
Georgina V. Long
Richard A. Scolyer
Brian Brown
Bin Zheng
Emily Bernstein
author_sort Thomas Strub
title SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
title_short SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
title_full SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
title_fullStr SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
title_full_unstemmed SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
title_sort sirt6 haploinsufficiency induces brafv600e melanoma cell resistance to mapk inhibitors via igf signalling
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/bec741aeed1b4f7292b8e63eab1bc699
work_keys_str_mv AT thomasstrub sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT flaviagghiraldini sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT saulcarcamo sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT manli sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT aleksandrawroblewska sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT rajendrasingh sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT matthewsgoldberg sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT danhasson sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT zichenwang sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT stuartjgallagher sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT peterhersey sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT avimaayan sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT georginavlong sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT richardascolyer sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT brianbrown sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT binzheng sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
AT emilybernstein sirt6haploinsufficiencyinducesbrafv600emelanomacellresistancetomapkinhibitorsviaigfsignalling
_version_ 1718380696613945344